BioCryst Pharmaceuticals, Inc. (BCRX) vs Phibro Animal Health Corporation (PAHC)
- BioCryst Pharmaceuticals, Inc. BCRX 7.79 −2.87%
- Phibro Animal Health Corporation PAHC 38.82 +2.21%
BioCryst Pharmaceuticals, Inc. and Phibro Animal Health Corporation are both Drug Manufacturers Specialty & Generic companies. BioCryst Pharmaceuticals, Inc. is the larger, with a market value of $2.1B against $1.5B — 1.3× the size. BioCryst Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Phibro Animal Health Corporation trades at 15.8×. BioCryst Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 68.7% against 17.1%. Phibro Animal Health Corporation has the higher net margin (6.57% vs −40.9%) and the higher return on invested capital (11.7% vs −610.6%). Across the 19 metrics below, BioCryst Pharmaceuticals, Inc. leads on 10 and Phibro Animal Health Corporation on 9.
Valuation
Profitability
| Metric | BCRX | PAHC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 97.78% | 33.76% | 53.94% |
| Operating margin | (33.29%) | 12.81% | 0.00% |
| Net margin | (40.90%) | 6.57% | 0.00% |
| Free cash flow margin | 39.75% | 0.65% | 0.00% |
| Return on equity | 87.84% | 29.72% | (0.40%) |
| Return on assets | (75.79%) | 6.97% | (3.32%) |
| Return on invested capital | (610.55%) | 11.72% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack